Appili Therapeutics Inc Class A (TSE:APLI) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Appili Therapeutics Inc. is set to hold a special shareholder meeting to vote on the acquisition of the company by Aditxt Inc., where shareholders will receive a combination of cash and Aditxt stock per Appili share. This arrangement, recommended by Appili’s board, offers a significant premium on Appili’s recent trading price and is expected to accelerate the development of Appili’s infectious disease programs through enhanced capital access and commercialization support.
For further insights into TSE:APLI stock, check out TipRanks’ Stock Analysis page.